Difficult to Express Proteins
Successfully expressing and purifying proteins can be difficult. Our team is often called upon to stably express and purify novel molecules that are challenging due to folding problems, toxicity to hosts, purification issues or any of a wide range of other problems. Our approach of continually optimizing and improving processes and assays enables our scientists to custom tailor the CLD process to your specific requirements.
Regulatory Friendly and Royalty Free
Our process has complete freedom to operate and comes with no clinical milestones or commercial royalties. In addition, the core technology has been reviewed many times over many years by the various regulatory agencies of the world. As such, this platform is well-documented and comes with very little regulatory risk.
What to Expect – Timelines and Titers
For protein expression projects requiring large amount of protein, the volumetric titer is critical to meeting the budget for manufacturing efforts. Our platform is very competitive with respect to its timeline to delivery and the titers obtained.
As every project is unique, we welcome the opportunity to discuss your stable protein expression needs. Contact us today.